![Molly Harper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Molly Harper
Plus aucun poste en cours
Profil
Molly Harper formerly worked at PreciseDx Ltd., as Director, Catalyst Pharmaceuticals, Inc., as Independent Director from 2021 to 2026, Genzyme Corp., as Head-Endocrinology Division, Relmada Therapeutics, Inc., as Executive Vice President-Operations, Akcea Therapeutics, Inc., as Senior Vice President, and Synlogic, Inc., as Chief Business Officer from 2021 to 2024.
Ms. Harper received her undergraduate degree from Cornell University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Molly Harper
| Sociétés | Poste | Fin |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 15/07/2026 |
| SYNLOGIC, INC. | Corporate Officer/Principal | 01/01/2024 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
PreciseDx Ltd.
 PreciseDx Ltd. Data Processing ServicesTechnology Services Provides patient-specific insights through AI-driven pathology tests and labs | Directeur/Membre du Conseil | - |
Formation de Molly Harper
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Relmada Therapeutics, Inc.
 Relmada Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products for the treatment of depression and other central nervous system diseases | Health Technology |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for cardiometabolic lipid disorders | Health Technology |
Synlogic, Inc.
 Synlogic, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
PreciseDx Ltd.
PreciseDx Ltd. Data Processing ServicesTechnology Services Provides patient-specific insights through AI-driven pathology tests and labs | Technology Services |
